Faris Al‐Khalili

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 880 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 756 citations · Full text

Medicine, Cardiology, Pharmacology +13

Mass Screening for Untreated Atrial Fibrillation

Emma Svennberg, Johan Engdahl, Faris Al‐Khalili et al. · Circulation · 2015 · 603 citations

Medicine, Cardiology, Internal Medicine +16

Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial

Emma Svennberg, Leif Friberg, Viveka Frykman et al. · The Lancet · 2021 · 348 citations

Medicine, Cardiology, Clinical Sciences +15

Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording

Mattias Aronsson, Emma Svennberg, Mårten Rosenqvist et al. · EP Europace · 2015 · 158 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +17